Blonder Tongue Laboratories, Inc.
BDRL
$0.10
-$0.10-50.00%
| 12/31/2022 | 09/30/2022 | 06/30/2022 | 03/31/2022 | 12/31/2021 | |
|---|---|---|---|---|---|
| Revenue | 18.12M | 16.83M | 15.74M | 15.84M | 15.75M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 18.12M | 16.83M | 15.74M | 15.84M | 15.75M |
| Cost of Revenue | 12.65M | 12.05M | 10.87M | 10.43M | 9.90M |
| Gross Profit | 5.46M | 4.78M | 4.87M | 5.41M | 5.86M |
| SG&A Expenses | 5.82M | 5.92M | 5.96M | 6.04M | 6.23M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | 1.80M | 1.19M | 1.19M | 1.19M |
| Total Operating Expenses | 20.25M | 21.87M | 20.39M | 20.15M | 19.90M |
| Operating Income | -2.13M | -5.04M | -4.65M | -4.30M | -4.15M |
| Income Before Tax | -2.92M | -3.92M | -3.42M | -641.00K | 99.00K |
| Income Tax Expenses | -- | 15.00K | 15.00K | 15.00K | 15.00K |
| Earnings from Continuing Operations | -2.92 | -3.94 | -3.44 | -0.66 | 0.08 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -2.92M | -3.94M | -3.44M | -656.00K | 84.00K |
| EBIT | -2.13M | -5.04M | -4.65M | -4.30M | -4.15M |
| EBITDA | -2.01M | -4.86M | -4.41M | -4.00M | -3.81M |
| EPS Basic | -0.22 | -0.30 | -0.26 | -0.04 | 0.01 |
| Normalized Basic EPS | -0.14 | -0.28 | -0.25 | -0.21 | -0.17 |
| EPS Diluted | -0.22 | -0.32 | -0.29 | -0.09 | -0.04 |
| Normalized Diluted EPS | -0.14 | -0.28 | -0.25 | -0.20 | -0.17 |
| Average Basic Shares Outstanding | 53.12M | 52.51M | 51.41M | 50.07M | 48.60M |
| Average Diluted Shares Outstanding | 53.12M | 52.51M | 51.41M | 53.34M | 51.87M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
